Document is current
Any future updates will be listed below
-
Authors
Gnatienko, Natalia
Lioznov, Dmitry
Raj, Anita
Blokhina, Elena
Rosen, Sydney
Cheng, Debbie M.
Lunze, Karsten
Bendiks, Sally
Truong, Ve
Bushara, Natalia
Toussova, Olga
Quinn, Emily
Krupitsky, Evgeny
Samet, Jeffrey H. https://orcid.org/0000-0002-0897-3400
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03290391 at ClinicalTrials.govDocuments that mention this clinical trial
Design of a randomized controlled trial to Link Infectious and Narcology Care (LINC-II) in St. Petersburg, Russia
https://doi.org/10.1186/s13722-020-0179-8
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA045547)
Providence/Boston Center for AIDS Research (P30AI042853)
- License Information
-
More Information
Article History
Received: 20 September 2019
Accepted: 4 January 2020
First Online: 13 January 2020
Ethics approval and consent to participate
: The LINC-II study was approved by the Institutional Review Boards of Boston University Medical Campus (H-36706) and First St. Petersburg Pavlov State Medical University. All study participants complete the informed consent process including written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
